lung-neoplasms

Documents about lung-neoplasms

• Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients#842297ClinicalTrials.gov
• Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer#898458ClinicalTrials.gov
• Characteristics of lung nodules detected by low-dose CT scan: Results from the French lung cancer screening study DEP KP-80#161178HAL (France)
• Muco-active Agent Use and Clinical Outcomes After Lung Cancer Diagnosis in Chronic Obstructive Pulmonary Disease#880801ClinicalTrials.gov
• Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)#1030691ClinicalTrials.gov
• A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer#915641ClinicalTrials.gov
• Study Evaluating Hemay020 In Subjects With Advanced Solid Cancer#904847ClinicalTrials.gov
• Intelligent Support for Radiological Reporting of Lung Neoplasms#968902ClinicalTrials.gov
• Integrating bulk and single-cell transcriptomic data to construct a risk model for histidine metabolism-related epithelial cell features in lung adenocarcinoma, predicting prognosis and immune landscape.#140928PubMed
• Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study#833194ClinicalTrials.gov
• A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors#874095ClinicalTrials.gov
• Does Intense Regimented Surveillance Improve the Rates of Therapeutic Re-Intervention After Lung Cancer Surgery#827062ClinicalTrials.gov
• Early Detection of Lung Cancer With Machine Learning Based on Routine Clinical Investigations#898469ClinicalTrials.gov
• First in Human Study of AZD9592 in Solid Tumors#803531ClinicalTrials.gov
• A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body#804452ClinicalTrials.gov
• Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies#862597ClinicalTrials.gov
• Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC#980208ClinicalTrials.gov
• Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC#651252ClinicalTrials.gov
• Systemic, Intrapulmonary and Pleural Inflammatory Reaction in Patients Undergoing Thoracic Surgery#901919ClinicalTrials.gov
• Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC#888206ClinicalTrials.gov
• Reshaping immunotherapy sequencing strategy: equivalent survival with induction plus consolidation vs. consolidation-only strategy in unresectable stage III NSCLC.#193910PubMed
• Integrated approach of guided honest disclosure and palliative care for advanced lung cancer: impacts on emotional distress, symptom burden, and patient satisfaction.#400697PubMed
• Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC#801759ClinicalTrials.gov
• Construction and Feasibility Study of a Home-Based Intelligent Symptom Management Program for Lung Cancer Patients Receiving Combined Drug Therapy Based on Symptom Journey Profiling#877311ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression#875371ClinicalTrials.gov
• A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers#803305ClinicalTrials.gov
• A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy#872998ClinicalTrials.gov
• A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations#968806ClinicalTrials.gov
• Uncovering the mechanisms of synergistic drug combinations in non-small cell lung cancer through metagene-based classification#174821PLOS
• Crizotinib Expanded Access Protocol For ROS1 Positive NSCLC#994348ClinicalTrials.gov
• A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3#896624ClinicalTrials.gov
• SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLC#878606ClinicalTrials.gov
• Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy#272351ClinicalTrials.gov
• Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1#1033406ClinicalTrials.gov
• Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer#844819ClinicalTrials.gov
• Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC)#884735ClinicalTrials.gov
• Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation#845603ClinicalTrials.gov
• Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery#888575ClinicalTrials.gov
• Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study#1032990ClinicalTrials.gov
• Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers#882356ClinicalTrials.gov
• A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours#881097ClinicalTrials.gov
• Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas#893430ClinicalTrials.gov
• Inhaled mRNA Immunotherapy for Patients With Advanced Lung Cancer or Pulmonary Metastatic Solid Tumors#311119ClinicalTrials.gov
• Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC#840570ClinicalTrials.gov
• An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation#908236ClinicalTrials.gov
• Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas#353265ClinicalTrials.gov
• A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers#917642ClinicalTrials.gov
• This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091#897205ClinicalTrials.gov
• Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer#127593ClinicalTrials.gov
• Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2#811995ClinicalTrials.gov